Extended window
Up to eight hours of hypothermic machine perfusion — roughly doubling the cold-storage ceiling.
For OPO Teams
More viable hearts.
Fewer constraints.
OPOs face outcome measures tied to donation rates, organ utilization, and timely transplant performance. VP.S ENCORE® supports these demands with a portable, bloodless system designed to reduce transport constraints and expand access to viable donor hearts.
• 01
The numbers behind the urgency.
Transplanted30%Of available donor hearts successfully placed.
Cold Storage4hrsBaseline viability window.
Waiting100k+Patients awaiting transplant nationally.
• 02
Four operational advantages.
Single-person handling
Portable, long-life battery. No specialty transport. No additional team headcount.
Built-in fallback
Automatic cold-storage mode protects the organ if circulation is interrupted mid-transport.
Standardized materials
Familiar components and FDA-approved perfusate. No specialty reagents, no blood products.
• 03
Built for the metrics that matter.
- Donation Rate
- Extended viability expands the pool of hearts that can reach a recipient within window.
- Organ Utilization Rate
- Fewer discards due to ischemic-time logistics. More of what is recovered becomes transplantable.
- Transport Flexibility
- Standard transport modes. No specialty aircraft, no blood-chain coordination.
- Timely Recovery
- Setup integrates with existing recovery protocols — retrieval teams stay in familiar workflows.
- Retrieval-Team Efficiency
- Single-person handling reduces staffing load and simplifies on-call logistics.
• 04
Fits your existing workflow.
VP.S ENCORE® is designed around familiar, standardized materials. Retrieval teams work within protocols they already know — no new reagents to stock, no specialty transport to schedule, and no blood products in the chain of custody.
Less that is new. More that just works.